Rumored Buzz on Healthcare News
FTC sues major pharmacy profit supervisors above insulin prices The agency introduced motion versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing cost of daily life-saving insulin medicine.Previously this summer time, the firm held prolonged negotiat